日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

ME3BP-7 is a targeted cytotoxic agent that rapidly kills pancreatic cancer cells expressing high levels of monocarboxylate transporter MCT1

ME3BP-7 是一种靶向细胞毒性药物,可快速杀死高表达单羧酸转运蛋白 MCT1 的胰腺癌细胞。

Jordina Rincon-Torroella # ,Marco Dal Molin # ,Brian Mog ,Gyuri Han ,Evangeline Watson ,Nicolas Wyhs ,Shun Ishiyama ,Taha Ahmedna ,Il Minn ,Nilofer Azad ,Chetan Bettegowda ,Nickolas Papadopoulos ,Kenneth W Kinzler ,Shibin Zhou ,Bert Vogelstein ,Kathleen Gabrielson ,Surojit Sur

Context-Dependent Immunomodulatory Effects of MEK Inhibition Are Enhanced with T-cell Agonist Therapy

细胞激动剂疗法可增强 MEK 抑制的环境相关免疫调节作用

Lauren Dennison, Amanda Ruggieri, Aditya Mohan, James Leatherman, Kayla Cruz, Skylar Woolman, Nilofer Azad, Gregory B Lesinski, Elizabeth M Jaffee, Mark Yarchoan

GPX3 promoter methylation predicts platinum sensitivity in colorectal cancer

GPX3 启动子甲基化可预测结直肠癌的铂敏感性

Lorraine Pelosof, Sashidhar Yerram, Todd Armstrong, Nina Chu, Ludmila Danilova, Breann Yanagisawa, Manuel Hidalgo, Nilofer Azad, James G Herman

Translational predictive biomarker analysis of the phase 1b sorafenib and bevacizumab study expansion cohort

1b 期索拉非尼和贝伐单抗研究扩展队列的转化预测生物标志物分析

Nilofer Azad, Minshu Yu, Ben Davidson, Peter Choyke, Clara C Chen, Bradford J Wood, Aradhana Venkatesan, Ryan Henning, Kathy Calvo, Lori Minasian, Daniel C Edelman, Paul Meltzer, Seth M Steinberg, Christina M Annunziata, Elise C Kohn